Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic

European Journal of Internal Medicine

Volumn 22, Issue 4, 2011, Pages 424-427

  Goland, Sorel ^a   Naugolny, Vladimir ^a   Korbut, Zila ^a   Rozen, Izabella ^a   Caspi, Abraham ^a   Malnick, Steven ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Complications; Congestive heart failure; Spironolactone treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; LOSARTAN; METOPROLOL; SPIRONOLACTONE; VALSARTAN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIAC PATIENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GYNECOMASTIA; HUMAN; HYPERKALEMIA; HYPONATREMIA; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SIDE EFFECT;

AGED; ALDOSTERONE ANTAGONISTS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALS, SPECIAL; HUMANS; HYPERKALEMIA; MALE; RETROSPECTIVE STUDIES; SPIRONOLACTONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960557021     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.04.008     Document Type: Article

References (21)

1. V.J. Dzau, W.S. Colucci, N.K. Hollenberg, and G.H. Williams Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure Circulation 63 1981 645 651 (Pubitemid 11139875)
2. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality Circulation 82 1990 1730 1736 (Pubitemid 20367976)
3. K.T. Weber, and D. Villarreal Aldosterone and antialdosterone therapy in congestive heart failure Am J Cardiol 71 1993 3A 11A (Pubitemid 23046405)
4. R.J. MacFadyen, C.S. Barr, and A.D. Struthers Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients Cardiovasc Res 35 1997 30 34 (Pubitemid 27374737)
5. W. Wang Chronic administration of aldosterone depresses baroreceptor reflex function in the dog Hypertension 24 1994 571 575 (Pubitemid 24337826)
6. D.A. Duprez, M.L. De Buyzere, E.R. Rietzschel, Y. Taes, D.L. Clement, and D. Morgan Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients Eur Heart J 19 1998 1371 1376 (Pubitemid 28427139)
7. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
8. The RALES Investigators Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]) Am J Cardiol 78 1996 902 907
9. B. Bozkurt, I. Agoston, and A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 2003 211 214 (Pubitemid 36092186)
10. K.B. Shah, K. Rao, R. Sawyer, and S.S. Gottlieb The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure J Am Coll Cardiol 46 2005 845 849 (Pubitemid 41224809)
11. B. Bozkurt, I. Agoston, and A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 2003 211 214 (Pubitemid 36092186)
12. W.B. Kannel Incidence and epidemiology of heart failure Heart Fail Rev 5 2000 167 173
13. D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, and A. Laupacis Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551 (Pubitemid 39025171)
14. K.B. Shah, K. Rao, R. Sawyer, and S.S. Gottlieb The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure J Am Coll Cardiol 46 2005 845 849 (Pubitemid 41224809)
15. C.S. Cruz, A.A. Cruz, and Marcilio de Souza C.A. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone Nephrol Dial Transplant 18 2003 1814 1819 (Pubitemid 37098553)
16. M. Svensson, F. Gustafsson, S. Galatius, P.R. Hildebrandt, and D. Atar How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 10 2004 297 303 (Pubitemid 39092680)
17. K.P. Tamirisa, K.D. Aaronson, and T.M. Koelling Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure Am Heart J 148 2004 971 978 (Pubitemid 39646969)
18. B. Waldum, A.S. Westheim, and L. Sandvik Renal function in outpatients with chronic heart failure J Card Fail 16 2010 374 380
19. J.H. O'Keefe, H. Abuissa, and B. Pitt Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS Diabetes Obes Metab 10 2008 492 497 (Pubitemid 351639092)
20. F. Zannad, J.J.V. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
21. Heart failure society of America Journal of Cardiac Failure 12 2006 10 38